149 related articles for article (PubMed ID: 18494807)
1. Novel pathways for glycaemic control in type 2 diabetes: focus on bile acid modulation.
Brinton EA
Diabetes Obes Metab; 2008 Nov; 10(11):1004-11. PubMed ID: 18494807
[TBL] [Abstract][Full Text] [Related]
2. Modulating LDL cholesterol and glucose in patients with type 2 diabetes mellitus: targeting the bile acid pathway.
Goldfine AB
Curr Opin Cardiol; 2008 Sep; 23(5):502-11. PubMed ID: 18670263
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
Kobayashi M; Ikegami H; Fujisawa T; Nojima K; Kawabata Y; Noso S; Babaya N; Itoi-Babaya M; Yamaji K; Hiromine Y; Shibata M; Ogihara T
Diabetes; 2007 Jan; 56(1):239-47. PubMed ID: 17192488
[TBL] [Abstract][Full Text] [Related]
4. Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus.
Levy P
Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S9-13. PubMed ID: 20946010
[TBL] [Abstract][Full Text] [Related]
5. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors.
Reasner CA
J Cardiovasc Pharmacol; 2008 Aug; 52(2):136-44. PubMed ID: 18670366
[TBL] [Abstract][Full Text] [Related]
6. Bile acid sequestrants: glucose-lowering mechanisms.
Prawitt J; Staels B
Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S3-8. PubMed ID: 20977365
[TBL] [Abstract][Full Text] [Related]
7. A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus.
Staels B
Postgrad Med; 2009 May; 121(3 Suppl 1):25-30. PubMed ID: 19494475
[TBL] [Abstract][Full Text] [Related]
8. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.
Corsini A; Windler E; Farnier M
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992
[TBL] [Abstract][Full Text] [Related]
9. Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion.
Sonne DP; Hansen M; Knop FK
Eur J Endocrinol; 2014 Aug; 171(2):R47-65. PubMed ID: 24760535
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
Goldberg RB; Fonseca VA; Truitt KE; Jones MR
Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
[TBL] [Abstract][Full Text] [Related]
11. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
Hou R; Goldberg AC
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review.
Insull W
South Med J; 2006 Mar; 99(3):257-73. PubMed ID: 16553100
[TBL] [Abstract][Full Text] [Related]
13. The role of bile acid sequestrants in the management of type 2 diabetes mellitus: summary and future directions.
Handelsman Y
Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S23-4. PubMed ID: 21142816
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced effects on cholesterol catabolism and bile acids.
Gylling H; Miettinen TA
Curr Opin Investig Drugs; 2006 Mar; 7(3):214-8. PubMed ID: 16555681
[TBL] [Abstract][Full Text] [Related]
15. A new use for an old drug provides dual glucose and LDL-lowering therapy in the modern setting of T2D management: colesevelam HCL.
Goldberg RB
Curr Diab Rep; 2009 Oct; 9(5):331-2. PubMed ID: 19793501
[No Abstract] [Full Text] [Related]
16. New therapies on the horizon.
Brown WV
Am J Manag Care; 2001 May; 7(5 Suppl):S148-51. PubMed ID: 11383377
[TBL] [Abstract][Full Text] [Related]
17. Bile acid sequestrants and the treatment of type 2 diabetes mellitus.
Staels B; Kuipers F
Drugs; 2007; 67(10):1383-92. PubMed ID: 17600387
[TBL] [Abstract][Full Text] [Related]
18. Bile acid sequestrants as a therapeutic option for glucose lowering in type 2 diabetes mellitus.
Levy P
Endocr Pract; 2008; 14(5):644-7. PubMed ID: 18753111
[No Abstract] [Full Text] [Related]
19. Metabolic effects of bile acid sequestration: impact on cardiovascular risk factors.
Spinelli V; Chávez-Talavera O; Tailleux A; Staels B
Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):138-44. PubMed ID: 26859552
[TBL] [Abstract][Full Text] [Related]
20. Interrupting bile-acid handling and lipid and glucose control: Effects of colesevelam on glucose levels.
Davidson MH
J Clin Lipidol; 2008 Apr; 2(2):S29-33. PubMed ID: 21291718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
